Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Co-Occurrence of IgA Antibodies Against Ethanol Metabolites and Tissue Transglutaminase in Alcohol Consumers: Correlation with Proinflammatory Cytokines and Markers of Fibrogenesis

Authors: Heidi Koivisto, Johanna Hietala, Petra Anttila, Onni Niemelä

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

IgA antibodies to tissue transglutaminase have been suggested to be specific indicators of celiac disease. However, no studies have addressed the relationships between such antibodies and alcohol abuse, which is also a common cause of IgA-isotype immune responses and tissue injury in the gastrointestinal tract and liver. Here, measurements of specific IgAs against tissue transglutaminase and proteins modified by acetaldehyde, the first metabolite of ethanol, showed significantly higher levels of both antibodies in alcoholic liver disease patients than in healthy controls or heavy drinkers without liver disease. These antibodies also significantly co-occurred in heavy drinkers without liver disease, moderate drinkers, and abstainers, and correlated with biomarkers of alcohol consumption, proinflammatory cytokines and markers of fibrogenesis. The data suggests a link between such immune responses, perturbations in cytokine profiles and fibrogenesis, which should be implicated in studies on the pathogenesis and diagnosis of ethanol-induced tissue injury and celiac disease.
Literature
1.
go back to reference Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Holmberg L, Kim DH, Malila N, Miller AB, Pietinen P, Rohan TE, Sellers TA, Speizer FE, Willett WC, Wolk A, Hunter DJ (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140:603–613PubMed Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Holmberg L, Kim DH, Malila N, Miller AB, Pietinen P, Rohan TE, Sellers TA, Speizer FE, Willett WC, Wolk A, Hunter DJ (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140:603–613PubMed
2.
go back to reference Laheij RJ, Verlaan M, Van Oijen MG, De Doelder MS, Dejong CA, Jansen JB (2004) Gastrointestinal symptoms and ethanol metabolism in alcoholics. Dig Dis Sci 49:1007–1011PubMedCrossRef Laheij RJ, Verlaan M, Van Oijen MG, De Doelder MS, Dejong CA, Jansen JB (2004) Gastrointestinal symptoms and ethanol metabolism in alcoholics. Dig Dis Sci 49:1007–1011PubMedCrossRef
4.
go back to reference Seitz HK, Salaspuro M, Savolainen M, Haber P, Ishii H, Teschke R, Moshage H, Lieber CS (2005) From alcohol toxicity to treatment. Alcohol Clin Exp Res 29:1341–1350PubMedCrossRef Seitz HK, Salaspuro M, Savolainen M, Haber P, Ishii H, Teschke R, Moshage H, Lieber CS (2005) From alcohol toxicity to treatment. Alcohol Clin Exp Res 29:1341–1350PubMedCrossRef
5.
6.
go back to reference Salaspuro MP (2003) Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 40:183–208PubMedCrossRef Salaspuro MP (2003) Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 40:183–208PubMedCrossRef
7.
go back to reference Seitz HK, Gartner U, Egerer G, Simanowski UA (1994) Ethanol metabolism in the gastrointestinal tract and its possible consequences. Alcohol Alcohol Suppl 2:157–162PubMed Seitz HK, Gartner U, Egerer G, Simanowski UA (1994) Ethanol metabolism in the gastrointestinal tract and its possible consequences. Alcohol Alcohol Suppl 2:157–162PubMed
8.
go back to reference Visapää JP, Jokelainen K, Nosova T, Salaspuro M (1998) Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin. Alcohol Clin Exp Res 22:1161–1164PubMedCrossRef Visapää JP, Jokelainen K, Nosova T, Salaspuro M (1998) Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin. Alcohol Clin Exp Res 22:1161–1164PubMedCrossRef
9.
go back to reference Latvala J, Hietala J, Koivisto H, Järvi K, Anttila P, Niemelä O (2005) Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 100:1303–1310PubMedCrossRef Latvala J, Hietala J, Koivisto H, Järvi K, Anttila P, Niemelä O (2005) Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. Am J Gastroenterol 100:1303–1310PubMedCrossRef
10.
go back to reference Tuma DJ, Klassen LW (1992) Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology 103:1969–1973PubMed Tuma DJ, Klassen LW (1992) Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. Gastroenterology 103:1969–1973PubMed
11.
go back to reference Worrall S, de Jersey J, Shanley BC, Wilce PA (1991) Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics. Eur J Clin Invest 21:90–95PubMedCrossRef Worrall S, de Jersey J, Shanley BC, Wilce PA (1991) Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics. Eur J Clin Invest 21:90–95PubMedCrossRef
12.
go back to reference Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396PubMedCrossRef Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396PubMedCrossRef
13.
go back to reference Martin A, Romito G, Pepe I, De Vivo G, Merola MR, Limatola A, Gentile V (2006) Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic. Curr Med Chem 13:1895–1902PubMedCrossRef Martin A, Romito G, Pepe I, De Vivo G, Merola MR, Limatola A, Gentile V (2006) Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic. Curr Med Chem 13:1895–1902PubMedCrossRef
15.
go back to reference Wodzinska JM (2005) Transglutaminases as targets for pharmacological inhibition. Mini Rev Med Chem 5:279–292PubMed Wodzinska JM (2005) Transglutaminases as targets for pharmacological inhibition. Mini Rev Med Chem 5:279–292PubMed
16.
go back to reference Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801PubMedCrossRef Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801PubMedCrossRef
17.
go back to reference Chand N, Mihas AA (2006) Celiac disease: current concepts in diagnosis and treatment. J Clin Gastroenterol 40:3–14PubMedCrossRef Chand N, Mihas AA (2006) Celiac disease: current concepts in diagnosis and treatment. J Clin Gastroenterol 40:3–14PubMedCrossRef
19.
go back to reference Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Höpfl P, Knip M (2003) Prevalence of celiac disease among children in Finland. N Engl J Med 348:2517–2524PubMedCrossRef Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Höpfl P, Knip M (2003) Prevalence of celiac disease among children in Finland. N Engl J Med 348:2517–2524PubMedCrossRef
20.
go back to reference Sanders DS, Hurlstone DP (2005) Do patients with unrecognized coeliac disease present as an emergency? Eur J Emerg Med 12:303–305PubMedCrossRef Sanders DS, Hurlstone DP (2005) Do patients with unrecognized coeliac disease present as an emergency? Eur J Emerg Med 12:303–305PubMedCrossRef
21.
go back to reference Orrego H, Israel Y, Blake JE, Medline A (1983) Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology 3:896–905PubMedCrossRef Orrego H, Israel Y, Blake JE, Medline A (1983) Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology 3:896–905PubMedCrossRef
22.
go back to reference Orrego H, Blake JE, Blendis LM, Medline A (1987) Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92:208–214PubMed Orrego H, Blake JE, Blendis LM, Medline A (1987) Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 92:208–214PubMed
23.
go back to reference Hietala J, Koivisto H, Latvala J, Anttila P, Niemelä O (2006) IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers. Alcohol Clin Exp Res 30:1693–1698PubMedCrossRef Hietala J, Koivisto H, Latvala J, Anttila P, Niemelä O (2006) IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers. Alcohol Clin Exp Res 30:1693–1698PubMedCrossRef
24.
go back to reference Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, Gulotta G, Averna MR, Montalto G, Mansueto S, Notarbartolo A (2002) Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 48:1546–1550PubMed Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, Gulotta G, Averna MR, Montalto G, Mansueto S, Notarbartolo A (2002) Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 48:1546–1550PubMed
25.
go back to reference Koop I, Ilchmann R, Izzi L, Adragna A, Koop H, Barthelmes H (2000) Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 95:2009–2014PubMedCrossRef Koop I, Ilchmann R, Izzi L, Adragna A, Koop H, Barthelmes H (2000) Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 95:2009–2014PubMedCrossRef
26.
go back to reference Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabó IR, Sarnesto A, Savilahti E, Collin P, Mäki M (1998) Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115:1322–1328PubMedCrossRef Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabó IR, Sarnesto A, Savilahti E, Collin P, Mäki M (1998) Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115:1322–1328PubMedCrossRef
27.
go back to reference Lo Iacono O, Petta S, Venezia G, Di Marco V, Tarantino G, Barbaria F, Mineo C, De Lisi S, Almasio PL, Craxì A (2005) Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?. Am J Gastroenterol 100:2472–2477PubMedCrossRef Lo Iacono O, Petta S, Venezia G, Di Marco V, Tarantino G, Barbaria F, Mineo C, De Lisi S, Almasio PL, Craxì A (2005) Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?. Am J Gastroenterol 100:2472–2477PubMedCrossRef
28.
go back to reference Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, de Franchis R (2003) High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 38:50–54PubMedCrossRef Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, de Franchis R (2003) High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 38:50–54PubMedCrossRef
29.
go back to reference Villalta D, Crovatto M, Stella S, Tonutti E, Tozzoli R, Bizzaro N (2005) False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta 356:102–109PubMedCrossRef Villalta D, Crovatto M, Stella S, Tonutti E, Tozzoli R, Bizzaro N (2005) False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta 356:102–109PubMedCrossRef
30.
go back to reference Dieterich W, Esslinger B, Trapp D, Hahn E, Huff T, Seilmeier W, Wieser H, Schuppan D (2006) Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 55:478–484PubMedCrossRef Dieterich W, Esslinger B, Trapp D, Hahn E, Huff T, Seilmeier W, Wieser H, Schuppan D (2006) Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 55:478–484PubMedCrossRef
31.
go back to reference Gianfrani C, Auricchio S, Troncone R (2005) Adaptive and innate immune responses in celiac disease. Immunol Lett 99:141–145PubMedCrossRef Gianfrani C, Auricchio S, Troncone R (2005) Adaptive and innate immune responses in celiac disease. Immunol Lett 99:141–145PubMedCrossRef
32.
go back to reference Hansson T, Dannaeus A, Klareskog L (1999) Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile. Clin Exp Immunol 116:246–250PubMedCrossRef Hansson T, Dannaeus A, Klareskog L (1999) Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile. Clin Exp Immunol 116:246–250PubMedCrossRef
33.
go back to reference Freeman TL, Tuma DJ, Thiele GM, Klassen LW, Worrall S, Niemelä O, Parkkila S, Emery PW, Preedy VR (2005) Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res 29:1310–1316PubMedCrossRef Freeman TL, Tuma DJ, Thiele GM, Klassen LW, Worrall S, Niemelä O, Parkkila S, Emery PW, Preedy VR (2005) Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res 29:1310–1316PubMedCrossRef
34.
go back to reference Israel Y, Hurwitz E, Niemelä O, Arnon R (1986) Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83:7923–7927PubMedCrossRef Israel Y, Hurwitz E, Niemelä O, Arnon R (1986) Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83:7923–7927PubMedCrossRef
35.
go back to reference Niemelä O (2001) Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 31:1533–1538PubMedCrossRef Niemelä O (2001) Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 31:1533–1538PubMedCrossRef
36.
go back to reference Tuma DJ, Newman MR, Donohue TM Jr, Sorrell MF (1987) Covalent binding of acetaldehyde to proteins: participation of lysine residues. Alcohol Clin Exp Res 11:579–584PubMedCrossRef Tuma DJ, Newman MR, Donohue TM Jr, Sorrell MF (1987) Covalent binding of acetaldehyde to proteins: participation of lysine residues. Alcohol Clin Exp Res 11:579–584PubMedCrossRef
37.
go back to reference Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS (1999) One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 13:143–148PubMedCrossRef Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS (1999) One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 13:143–148PubMedCrossRef
38.
go back to reference Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J (2006) Cytokines and alcohol. Alcohol Clin Exp Res 30:720–730PubMedCrossRef Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J (2006) Cytokines and alcohol. Alcohol Clin Exp Res 30:720–730PubMedCrossRef
39.
go back to reference Hill DB, Marsano LS, McClain CJ (1993) Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 18:576–580PubMedCrossRef Hill DB, Marsano LS, McClain CJ (1993) Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 18:576–580PubMedCrossRef
40.
go back to reference Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267–276PubMed Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267–276PubMed
41.
go back to reference McClain CJ, Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349–351PubMedCrossRef McClain CJ, Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9:349–351PubMedCrossRef
42.
go back to reference Neuman MG, Brenner DA, Rehermann B, Taieb J, Chollet-Martin S, Cohard M, Garaud JJ, Poynard T, Katz GG, Cameron RG, Shear NH, Gao B, Takamatsu M, Yamauchi M, Ohata M, Saito S, Maeyama S, Uchikoshi T, Toda G, Kumagi T, Akbar SM, Abe M, Michitaka K, Horiike N, Onji M (2001) Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 25:251S–253SPubMed Neuman MG, Brenner DA, Rehermann B, Taieb J, Chollet-Martin S, Cohard M, Garaud JJ, Poynard T, Katz GG, Cameron RG, Shear NH, Gao B, Takamatsu M, Yamauchi M, Ohata M, Saito S, Maeyama S, Uchikoshi T, Toda G, Kumagi T, Akbar SM, Abe M, Michitaka K, Horiike N, Onji M (2001) Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 25:251S–253SPubMed
43.
go back to reference Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917–920PubMed Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917–920PubMed
44.
go back to reference Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255–259PubMedCrossRef Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255–259PubMedCrossRef
45.
go back to reference Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD (1996) Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 24:377–384PubMedCrossRef Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD (1996) Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 24:377–384PubMedCrossRef
46.
go back to reference McClain C, Barve S, Joshi-Barve S, Song Z, Deaciuc I, Chen T, Hill D (2005) Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcohol Clin Exp Res 29:180S–188SPubMedCrossRef McClain C, Barve S, Joshi-Barve S, Song Z, Deaciuc I, Chen T, Hill D (2005) Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcohol Clin Exp Res 29:180S–188SPubMedCrossRef
47.
go back to reference Swiatkowska-Stodulska R, Bakowska A, Drobinska-Jurowiecka A (2006) Interleukin-8 in the blood serum of patients with alcoholic liver disease. Med Sci Monit 12:CR215–CR220PubMed Swiatkowska-Stodulska R, Bakowska A, Drobinska-Jurowiecka A (2006) Interleukin-8 in the blood serum of patients with alcoholic liver disease. Med Sci Monit 12:CR215–CR220PubMed
48.
go back to reference Colantoni A, Idilman R, De Maria N, La Paglia N, Belmonte J, Wezeman F, Emanuele N, Van Thiel DH, Kovacs EJ, Emanuele MA (2003) Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines. Alcohol Clin Exp Res 27:1184–1189PubMedCrossRef Colantoni A, Idilman R, De Maria N, La Paglia N, Belmonte J, Wezeman F, Emanuele N, Van Thiel DH, Kovacs EJ, Emanuele MA (2003) Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines. Alcohol Clin Exp Res 27:1184–1189PubMedCrossRef
49.
go back to reference Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG (1997) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530–1537PubMedCrossRef Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG (1997) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530–1537PubMedCrossRef
50.
go back to reference Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942–952PubMedCrossRef Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942–952PubMedCrossRef
51.
go back to reference Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ (2003) Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology 38:1178–1187PubMedCrossRef Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ (2003) Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology 38:1178–1187PubMedCrossRef
52.
go back to reference Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D (2004) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117:3389–3403PubMedCrossRef Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D (2004) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117:3389–3403PubMedCrossRef
53.
go back to reference Metzger MH, Heier M, Mäki M, Bravi E, Schneider A, Löwel H, Illig T, Schuppan D, Wichmann HE (2006) Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989–1998. Eur J Epidemiol 21:359–365PubMedCrossRef Metzger MH, Heier M, Mäki M, Bravi E, Schneider A, Löwel H, Illig T, Schuppan D, Wichmann HE (2006) Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989–1998. Eur J Epidemiol 21:359–365PubMedCrossRef
Metadata
Title
Co-Occurrence of IgA Antibodies Against Ethanol Metabolites and Tissue Transglutaminase in Alcohol Consumers: Correlation with Proinflammatory Cytokines and Markers of Fibrogenesis
Authors
Heidi Koivisto
Johanna Hietala
Petra Anttila
Onni Niemelä
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9874-5

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.